EKF Diagnostics (LON:EKF) Shares Down 6.8% – Should You Sell?

EKF Diagnostics Holdings plc (LON:EKF) shares dropped 6.8% on Tuesday . The company traded as low as GBX 25.35 and last traded at GBX 25.35. Approximately 345,551 shares were traded during trading, an increase of 27% from the average daily volume of 272,147 shares. The stock had previously closed at GBX 27.20.

EKF Diagnostics Price Performance

The firm has a market capitalization of £109.37 million, a price-to-earnings ratio of 18.67 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The company’s fifty day moving average is GBX 25.34 and its two-hundred day moving average is GBX 27.25.

Insider Transactions at EKF Diagnostics

In related news, insider Julian Baines bought 85,000 shares of EKF Diagnostics stock in a transaction on Monday, December 15th. The shares were purchased at an average price of GBX 23 per share, for a total transaction of £19,550. Company insiders own 39.62% of the company’s stock.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.